Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 55 Records) |
Query Trace: Myelofibrosis and IMPACT[original query] |
---|
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis. Annals of hematology 2019 Apr 98 (4): 869-879. Gill Harinder, Ip Ho-Wan, Yim Rita, Tang Wing-Fai, Pang Herbert H, Lee Paul, Leung Garret M K, Li Jamilla, Tang Karen, So Jason C C, Leung Rock Y Y, Li Jun, Panagioutou Gianni, Lam Clarence C K, Kwong Yok-L |
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea. Blood cancer journal 2018 11 8 (12): 122. Pacilli Annalisa, Rotunno Giada, Mannarelli Carmela, Fanelli Tiziana, Pancrazzi Alessandro, Contini Elisa, Mannelli Francesco, Gesullo Francesca, Bartalucci Niccolò, Fattori Giuditta Corbizi, Paoli Chiara, Vannucchi Alessandro M, Guglielmelli Pao |
Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer 2019 7 59 (1): 30-39. Courtier Frédéric, Garnier Séverine, Carbuccia Nadine, Guille Arnaud, Adélaide José, Chaffanet Max, Hirsch Pierre, Paz Damien Luque, Slama Bohrane, Vey Norbert, Ugo Valérie, Delhommeau François, Rey Jérome, Birnbaum Daniel, Murati An |
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression. British journal of haematology 2019 Nov . Cottin Laurane, Riou Jérémie, Orvain Corentin, Ianotto Jean Christophe, Boyer Françoise, Renard Maxime, Truchan-Graczyk Matgorzata, Murati Anne, Jouanneau-Courville Rébecca, Allangba Olivier, Mansier Olivier, Burroni Barbara, Rousselet Marie-Christine, Quintin-Roué Isabelle, Martin Antoine, Sadot-Lebouvier Sophie, Delneste Yves, Chrétien Jean-Marie, Hunault-Berger Mathilde, Blanchet Odile, Lippert Eric, Ugo Valérie, Luque Paz Dami |
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis. Leukemia 2019 Oct . Santos Fabio P S, Getta Bartlomiej, Masarova Lucia, Famulare Christopher, Schulman Jessica, Datoguia Tarcila S, Puga Renato D, Alves Paiva Raquel de Melo, Arcila Maria E, Hamerschlak Nelson, Kantarjian Hagop M, Levine Ross L, Campregher Paulo Vidal, Rampal Raajit K, Verstovsek Srd |
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 1 25 (6): 1142-1151. Tamari Roni, Rapaport Franck, Zhang Nan, McNamara Caroline, Kuykendall Andrew, Sallman David A, Komrokji Rami, Arruda Andrea, Najfeld Vesna, Sandy Lonette, Medina Juan, Litvin Rivka, Famulare Christopher A, Patel Minal A, Maloy Molly, Castro-Malaspina Hugo, Giralt Sergio A, Weinberg Rona S, Mascarenhas John O, Mesa Ruben, Rondelli Damiano, Dueck Amylou C, Levine Ross L, Gupta Vikas, Hoffman Ronald, Rampal Raajit |
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis. Clinical lymphoma, myeloma & leukemia 2020 8 20 (12): e956-e960. Castillo-Tokumori Franco, Talati Chetasi, Al Ali Najla, Sallman David, Yun Seongseok, Sweet Kendra, Padron Eric, Lancet Jeffrey, Komrokji Rami, Kuykendall Andrew |
A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients. BMC cancer 2020 3 20 (1): 205. Zaidi Uzma, Sufaida Gul, Rashid Munazza, Kaleem Bushra, Maqsood Sidra, Mukry Samina Naz, Khan Rifat Zubair Ahmed, Munzir Saima, Borhany Munira, Shamsi Tahir Sult |
The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms. Turkish journal of medical sciences 2021 9 52 (1): 150-165. ?ahin Ezgi, Yönal-Hindilerden ?pek, Hindilerden Fehmi, Aday Aynur, Nalçac? Meli |
Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis. Cancers 2021 May 13 (11): . Masselli Elena, Carubbi Cecilia, Pozzi Giulia, Percesepe Antonio, Campanelli Rita, Villani Laura, Gobbi Giuliana, Bonomini Sabrina, Roti Giovanni, Rosti Vittorio, Massa Margherita, Barosi Giovanni, Vitale Mar |
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study. British journal of haematology 2021 6 194 (3): 557-567. Bankar Aniket, Alibhai Shabbir, Smith Elliot, Yang Dongyang, Malik Sarah, Cheung Verna, Siddiq Nancy, Claudio Jaime, Arruda Andrea, Tsui Hubert, Capo-Chichi Jose-Mario, Kennedy James A, McNamara Caroline, Sibai Hassan, Maze Dawn, Xu Wei, Gupta Vik |
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study. Blood advances 2021 Mar 5 (5): 1442-1451. Luque Paz Damien, Riou Jérémie, Verger Emmanuelle, Cassinat Bruno, Chauveau Aurélie, Ianotto Jean-Christophe, Dupriez Brigitte, Boyer Françoise, Renard Maxime, Mansier Olivier, Murati Anne, Rey Jérôme, Etienne Gabriel, Mansat-De Mas Véronique, Tavitian Suzanne, Nibourel Olivier, Girault Stéphane, Le Bris Yannick, Girodon François, Ranta Dana, Chomel Jean-Claude, Cony-Makhoul Pascale, Sujobert Pierre, Robles Margot, Ben Abdelali Raouf, Kosmider Olivier, Cottin Laurane, Roy Lydia, Sloma Ivan, Vacheret Fabienne, Wemeau Mathieu, Mossuz Pascal, Slama Borhane, Cussac Vincent, Denis Guillaume, Walter-Petrich Anouk, Burroni Barbara, Jézéquel Nathalie, Giraudier Stéphane, Lippert Eric, Socié Gérard, Kiladjian Jean-Jacques, Ugo Valér |
The role of new technologies in myeloproliferative neoplasms: Application of next-generation sequencing in myelofibrosis. International journal of laboratory hematology 2021 3 43 (5): 1070-1077. Navrátilová Jana, Palová Miroslava, Szotkowski Tomáš, Hluší Antonín, Katrincsáková Beáta, Papajík Tomáš, Indrák Kar |
Predictive Value of miR-146a rs2431697 Polymorphism to Myelofibrosis Progression in Patients with Myeloproliferative Neoplasm. Asian Pacific journal of cancer prevention : APJCP 2021 Nov 22 (11): 3585-3589. Aref Salah, Atia Doaa, Al Tantawy Ahmed, Al Boghdady Mohamed, Gouda En |
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis. Annals of hematology 2021 Jan . Wang Ziqing, Liu Weiyi, Wang Mingjing, Li Yujin, Wang Xueying, Yang Erpeng, Ming Jing, Quan Richeng, Hu Xiaom |
The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis. Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 902-908. Pan Yuxia, Wang Xingzhe, Wen Shupeng, Liu Xiaojun, Yang Lin, Luo Jianm |
Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 6 43 (4): 323-329. Tan Y X, Luo J, Huang J X, Luo D M, Liang H Y, Zhou X, Liu X L, Xu |
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation. Pharmaceutics 2022 6 14 (6): . Dadkhah Adrin, Wicha Sebastian Georg, Kröger Nicolaus, Müller Alexander, Pfaffendorf Christoph, Riedner Maria, Badbaran Anita, Fehse Boris, Langebrake Claud |
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis. Cancers 2022 4 14 (7): . Cattaneo Daniele, Vener Claudia, Elli Elena Maria, Bucelli Cristina, Galli Nicole, Cavalca Fabrizio, Auteri Giuseppe, Vincelli Donatella, Martino Bruno, Gianelli Umberto, Palandri Francesca, Iurlo Alessand |
Essential Thrombocythemia: One-Center Data in a Changing Disease. Medicina (Kaunas, Lithuania) 2022 12 58 (12): . Pirciulescu Nicoleta, Gaman Mihnea-Alexandru, Mihailescu Marina, Constantin Cristina, Dragomir Mihaela, Dobrea Camelia, Costache Simona, Ursuleac Iulia, Coriu Daniel, Crisan Ana Manue |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. Frontiers in oncology 2023 9 13 1224590. Patryk Sobieralski, Bartosz Was?g, Aleksandra Leszczy?ska, Monika ?uk, Maria Bieniaszews |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2023 8 . ?pek Yönal-Hindilerden, Ezgi ?ahin, Fehmi Hindilerden, Aynur Da?lar-Aday, Meliha Nalça |
High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis. Journal of applied genetics 2023 7 . Zuzanna Kandu?a, Micha? Janowski, Barbara Wi?ckowska, Edyta Paczkowska, Aleksandra Mroczkowska-B?karciak, Marta Sobas, Krzysztof Lewandows |
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood 2023 3 . Gagelmann Nico, Badbaran Anita, Salit Rachel B, Schroeder Thomas, Gurnari Carmelo, Pagliuca Simona, Panagiota Victoria, Rautenberg Christina, Cassinat Bruno, Thol Felicitas R, Wolschke Christine, Robin Marie, Heuser Michael, Rubio Marie-Thérèse, Maciejewski Jaroslaw P, Reinhardt Hans Christian, Scott Bart L, Kröger Nicola |
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers 2023 3 15 (5): . Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio, Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobi |
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. American journal of hematology 2024 1 . Alberto Hernández-Sánchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Adrián Mosquera-Orgueira, María-Teresa Gómez-Casares, Francisca Ferrer-Marín, Esperanza Such, Patricia Velez, Rosa Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, Alicia Senín, José-María Raya, José Antonio González, Beatriz Cuevas, Blanca Xicoy, Manuel Pérez-Encinas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Jesús María Hernández-Rivas, Juan Carlos Hernández-Boluda, |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: